Edition:
United States

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

4.59USD
4:00pm EDT
Change (% chg)

$-0.13 (-2.75%)
Prev Close
$4.72
Open
$4.71
Day's High
$4.71
Day's Low
$4.43
Volume
48,996
Avg. Vol
50,460
52-wk High
$14.09
52-wk Low
$4.39

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 1.12 -0.584
Sep '17 1.47 -0.791
Jun '17 1.05 -0.537
Mar '17 1.68 -5.596
FY 2016 Dec '16
Sep '16 0.97 -0.658
Jun '16 1.78 -0.570
Mar '16 1.42 -6.421
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 1.24 1.80 1.00 --
Quarter Ending Sep-18 5 1.10 1.90 0.50 --
Year Ending Dec-18 6 4.90 7.40 3.00 5.92
Year Ending Dec-19 7 16.14 22.90 8.82 23.19
Earnings (per share)
Quarter Ending Jun-18 5 -0.56 -0.42 -0.74 --
Quarter Ending Sep-18 5 -0.54 -0.37 -0.75 --
Year Ending Dec-18 6 -2.18 -1.65 -2.85 -2.30
Year Ending Dec-19 7 -1.99 -1.05 -3.20 -13.74
LT Growth Rate (%) 2 25.75 97.20 -45.70 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.44 32.31
P/E High - Last 5 Yrs. -- 280.78 46.12
P/E Low - Last 5 Yrs. -- 95.19 24.71
Beta -- 0.75 0.79
Price to Sales (TTM) 32.86 144.18 7.14
Price to Book (MRQ) 2.11 18.80 4.88
Price to Tangible Book (MRQ) 2.13 23.34 6.49
Price to Cash Flow (TTM) -- 117.05 24.37
% Owned Institutions 78.47 11.29 2.32

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.58
Dividend Yield - 5 Year Avg -- 0.20 0.78
Dividend 5 Year Growth Rate -- 1.96 4.08
Payout Ratio(TTM) -- 9.23 21.09

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -51.37 103.37 9.18
Sales (TTM) vs TTM 1 Yr. Ago -17.94 79.40 11.01
Sales - 5 Yr. Growth Rate -- 33.48 8.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 96.74 -66.76 23.62
EPS (TTM) vs TTM 1 Yr. Ago 70.62 -- --
EPS - 5 Yr. Growth Rate -- 46.41 10.39
Capital Spending - 5 Yr. Growth Rate -- 44.90 10.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.70 2.52
Current Ratio (MRQ) 7.08 5.99 3.58
LT Debt to Equity (MRQ) 0.28 23.56 11.61
Total Debt to Equity (MRQ) 0.28 26.01 14.31
Interest Coverage (TTM) -- -183.16 30.88

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -252.49 31.78 54.20
Gross Margin - 5 Yr. Avg. -- 55.29 52.34
EBITD Margin (TTM) -1,378.76 -- --
EBITD - 5 Yr. Avg -- -149.45 15.90
Operating Margin (TTM) -1,386.88 -587.01 3.62
Operating Margin - 5 Yr. Avg. -- -161.52 11.17
Pre-Tax Margin (TTM) -1,372.46 -560.40 4.27
Pre-Tax Margin - 5 Yr. Avg. -- -168.41 11.48
Net Profit Margin (TTM) -1,382.89 -548.74 0.90
Net Profit Margin - 5 Yr. Avg. -- -168.67 7.81
Effective Tax Rate (TTM) -- -0.45 31.67
Effective Tax Rate - 5 Yr. Avg. -- 18.02 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) 60,443 23,441,753 786,924,448
Net Income/Employee (TTM) -835,864 684,681 92,306,248
Receivable Turnover (TTM) 0.97 6.13 5.48
Inventory Turnover (TTM) -- 2.39 3.46
Asset Turnover (TTM) 0.06 0.40 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -77.84 -0.78 10.35
Return on Assets - 5 Yr. Avg. -- 0.53 11.38
Return on Investment (TTM) -92.02 -0.73 12.97
Return on Investment - 5 Yr. Avg. -- 3.99 14.74
Return on Equity (TTM) -92.34 -2.77 14.84
Return on Equity - 5 Yr. Avg. -- -0.21 16.08
  1 Year 3 Year 5 Year
Sales % -17.94 -- --
EPS (TTM) % 90.35 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nabriva Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.60 -6.39 34 7
13 Week -30.79 -25.42 20 58
26 Week -20.00 -21.99 30 87
52 Week -56.46 -60.76 15 78
YTD -21.07 -19.90 24 87
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.47%
# of Holders: 53
Total Shares Held: 28,809,777
3 Mo. Net Change: 3,411,234
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 4
# Reduced Positions: 2
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.